cardiac amyloidosis research hub

Prospective, monocentric, exploratory phase II study for the evaluation of the diagnostic use of the tracer PET (18F) -Flutemetamol (Vizamyl®) in patients with cardiac amyloidosis

This study is looking at a special scan called a PET scan to see how a new tracer (a tiny amount of a radioactive substance) called Vizamyl works. We want to see how much of it is taken up by the heart in people with different types of cardiac amyloidosis.

Test-retest Study With [18F]FBB in Cardiac Amyloidosis

This study looks at how well a special scan, called a PET scan, can consistently find deposits in the heart caused by a condition called cardiac amyloidosis. We will check if the scan gives reliable results when done more than once.

PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY

This study looks at whether checking your weight at home can help people with a heart condition called cardiac amyloidosis. It aims to see if spotting fluid build-up early can stop you from needing to go to hospital.

An open-label, multi-center, non-randomized pivotal Phase 3 study to evaluate the efficacy and safety of [18F]florbetaben Positron Emission Tomography (PET) imaging to diagnose cardiac AL amyloidosis